Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multinational, Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection

NCT04651400 is registered in ClinicalTrials.gov with Octapharma as lead sponsor.

NCT NCT04651400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04651400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multinational, Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection
Lead sponsor
Octapharma
Phase
Observational
Overall status
Completed
Start date
October 19, 2020
Completion date
September 27, 2022
Enrollment
300 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

covid19